US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jun 29, 2026 (2 months ago)

Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

What was recalled

Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-412-02

Recalling firm
Cipla USA, Inc.
NDC code
69097-412-02
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0676-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all